Analysts expect Vaxcyte, Inc. to report revenue of 0.00 for Q3 26, against a range of 0.00 to 0.00. The most recent reported quarter, Q2 26, came in at 0.00.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 9.00 M | 12.17 M | 40.35 M | 45.89 M | ||||||||||
| Low Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 7.48 M | 10.68 M | 35.13 M | 40.87 M | ||||||||||
| Consensus Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 8.24 M | 11.42 M | 37.74 M | 43.38 M |
Analysts expect Vaxcyte, Inc. to report earnings per share of -2.24 for Q3 26, against a range of -2.37 to -2.11. The most recent reported quarter, Q2 26, came in at -1.97, a 2.5% beat against the -2.02 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.83 | -1.02 | -1.04 | -1.22 | -1.56 | -1.81 | -2.30 | -1.97 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -0.99 | -1.04 | -1.01 | -1.08 | -1.23 | -1.38 | -1.57 | -1.82 | -2.11 | -1.99 | -1.11 | -1.19 | -1.82 | -1.82 | -1.28 | -1.15 | ||||||||||
| Low Estimate | -1.07 | -1.22 | -1.19 | -1.28 | -1.33 | -1.60 | -1.81 | -2.22 | -2.37 | -2.25 | -1.23 | -1.45 | -2.00 | -2.20 | -1.52 | -1.29 | ||||||||||
| Consensus Estimate | -1.03 | -1.13 | -1.10 | -1.18 | -1.28 | -1.49 | -1.69 | -2.02 | -2.24 | -2.12 | -1.17 | -1.32 | -1.91 | -2.01 | -1.40 | -1.22 |
Pull Wall Street consensus for Vaxcyte, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=PCVX&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "PCVX", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=PCVX&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();